Article Details

PDL BioPharma Liquidation May Offer 40% Upside For Patient Investors Comfortable With Illiquidity

Retrieved on: 2020-12-04 16:41:15

Tags for this article:

Click the tags to see associated articles and topics

PDL BioPharma Liquidation May Offer 40% Upside For Patient Investors Comfortable With Illiquidity. View article details on hiswai:

Excerpt

Pharma company PDL <b>BioPharma</b> (PDLI), with material royalty streams, has been in the process of unlocking the value of its portfolio since December ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up